Genetic Engineering & Biotechnology News

OCT15 2017

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/883455

Contents of this Issue

Navigation

Page 36 of 37

Tuesday, October 24, 2017 11:00 am ET 8: 00 am PT 5: 00 pm CET DURATION 60 minutes COST Complimentary Speakers Cell Culture Advances in the Age of Immunotherapy Cell-based immunotherapeutics have expanded the clinical drug repertoire for many diseases and provide immeasur- able hope for patients who are intractable to the standard of care treatments. Emboldened by the success of cell therapies, investigators are looking for improved modalities by which to generate novel treatments, as well as enhancing existing processes to improve production efficiencies and therapy efficacy. Join us for this upcoming GEN webinar where we will discuss some of the latest tools and technologies currently being employed to enhance immunotherapy culture conditions. A live Q&A session will follow the presentations, offering you a chance to pose questions to our expert panelists. Who Should Attend • Immunotherapy researchers • Cell therapy production scientistss • Scientists working in process development and biomanufacturing • Translational research scientists • Clinical researchers Free Registration! www.GENengnews.com/Advances Webinars You Will Learn • About the latest methodologies and improvements in cell culture conditions that will streamline laboratory and manufacturing workflows • How various immune cells are made under good manufacturing practices (GMP) conditions • About the importance of closed and automated manufacturing technologies Produced with support from John C. Bell, Ph.D. Senior Scientist, Cancer Therapeutics Program The Ottawa Hospital University of Ottawa Patrick J. Hanley, Ph.D. Assistant Professor and Laboratory Facility Director, Children's National Medical Center, The George Washington University Lior Raviv Vice President, Development Pluristem Therapeutics

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - OCT15 2017